ArticleCirculation reports2025

Rationale and Design of the ESPIAL Trial　- A Prospective, Randomized, Exploratory Study to Evaluate the Effect of Esaxerenone on Reduction of Urinary Albumin to Creatinine Ratio in Hypertensive Patients Concomitant With Heart Failure and Albuminuria.

Shinichiro Suna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.